Related Experiment Videos
Specific molecular interaction sites on factor VII involved in factor X activation
European Journal of Biochemistry
|October 15, 1993
Summary
This study identifies key binding sites on Factor VII (FVII) involved in initiating blood coagulation. Researchers pinpointed specific peptide sequences on FVII that interact with tissue factor and Factor X, crucial for blood clotting regulation.
Area of Science:
- Biochemistry
- Molecular Biology
- Hematology
Background:
- The extrinsic pathway of coagulation is initiated by a complex of Factor VII (FVII) and tissue factor (TF).
- Understanding FVII's functional sites is crucial for regulating coagulation and developing targeted therapies.
- Previous research focused on identifying inhibitory peptides and antibodies to map FVII interaction domains.
Purpose of the Study:
- To identify and characterize the specific molecular regions on Factor VII responsible for binding to tissue factor and Factor X.
- To determine the minimal peptide sequences within Factor VII that mediate these interactions.
- To elucidate the binding interactions between Factor VII and its cofactors in the coagulation cascade.
Main Methods:
- Synthesis and testing of a series of overlapping peptides representing the primary structure of Factor VII.
- Inhibition assays using peptides and antibodies to map functional sites.
- Binding studies using radiolabeled peptides and cell lines expressing tissue factor.
- Kinetic analyses and chemical cross-linking to confirm substrate recognition sites.
Main Results:
- Four high-affinity interactive regions on Factor VII were identified: peptides (44-50), (196-229), (285-305), and (376-396).
- The peptide sequence FVII-(196-229) contains the binding site for tissue factor, as demonstrated by inhibition of FVII binding to TF-expressing cells.
- Peptides FVII-(285-305) and FVII-(376-396) were identified as substrate-recognition sites for Factor X, binding specifically to its heavy chain.
Conclusions:
- Specific peptide sequences within Factor VII mediate its interactions with tissue factor and Factor X.
- The region FVII-(196-229) is critical for TF binding, while regions FVII-(285-305) and FVII-(376-396) are involved in FX recognition.
- These findings provide a detailed map of Factor VII's interaction sites, essential for understanding coagulation initiation and potential therapeutic interventions.